Moreover, the increased GFAP expression and decreased Ki-67 ratio in the concurrent group confirmed that the malignancy of C6 glioma decreased after the implantation of the BIC/PLGA nanofibrous membrane44, 46. The gene discussed is GFAP; the disease is central nervous system cancer.